Trading Signals: HALO Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Halozyme Therapeutics Inc)
| HALO latest price $40.4000 (0.71%) ($40.1000 - $40.4000) on Mon. Dec. 7, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.09% (three month average) | RSI | 57 | Latest Price | $40.4000(0.71%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | HALO advances 0.7% a day on average for past five trading days. | Weekly Trend | HALO advances 1% a week on average for past two weeks. | Market Behavior | Value stocks sell-off for large cap. Growth stock rally for small cap. | Correlated ETFs | Broad market will support HALO advance at 0% a week (0% probability) IBB(51%) IWO(51%) IWM(49%) IWC(46%) ARKG(43%) | Factors Impacting HALO price | HALO will decline at least -1.545% in a week (0% probabilities). VIXM(-31%) VXX(-13%) UUP(-13%) TLT(-0%) TBT(-0%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.545% (StdDev 3.09%) | Hourly BBV | 0.4 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $40.2(0.5%) | 10 Day Moving Average | $40.21(0.47%) | 20 Day Moving Average | $39.53(2.2%) | To recent high | -1.8% | To recent low | 57% | Market Cap | $5.522b | | | | Halozyme Therapeutics, Inc. is a biopharmaceutical company, which engages in research, development & commercialization of human enzymes and drug candidates. It focuses on novel oncology therapies that target the tumor microenvironment. Its products include PEGPH20, HTI-1511, PEG-ADA2, and HYLENEX recombinant. The company was founded by Gregory Ian Frost on February 26, 1998 and is headquartered in San Diego, CA. |